Major Pharmaceuticals Duloxetine Capsules Recall: Nitrosamine Impurity Risk
Major Pharmaceuticals recalls 20mg Duloxetine capsules due to potential nitrosamine impurities. This could pose health risks if consumed. Affected lots: N01530 (exp 01/2025) and N01540 (exp 01/2025).
Recall notice
CGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limit
Contact the company
What happened, in plain English
Major Pharmaceuticals is recalling 20mg Duloxetine Delayed-Release Capsules that may contain unsafe levels of nitrosamine impurities. This could pose health risks if taken as directed. The recall affects specific lot numbers with expiration dates in January 2025. Read more at govinfonow.com/recall/32333-major-pharmaceuticals-duloxetine-capsules-recall-nitrosamine-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/32333-major-pharmaceuticals-duloxetine-capsules-recall-nitrosamine-impurity-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0212-2025
Cite this page
“Major Pharmaceuticals Duloxetine Capsules Recall: Nitrosamine Impurity Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32333-major-pharmaceuticals-duloxetine-capsules-recall-nitrosamine-impurity-risk. Based on FDA recall #D-0212-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0212-2025%22&limit=1).
Why it’s dangerous
The capsules may contain nitrosamine impurities above FDA safety limits. Nitrosamines are known carcinogens that can increase cancer risk with long-term exposure. However, the exact health risk from this specific impurity level is not clearly stated in the recall.
Who’s affected
People who have the recalled lot numbers (N01530 or N01540) with expiration dates of January 2025. Prescriptions for this medication are typically for those with depression or back pain.
How to tell if you have this one
Check the blister pack for lot number N01530 (expiring 01/2025) or N01540 (expiring 01/2025). The product is a prescription-only 20mg Duloxetine capsule.
- Brand
Major Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Lot Number
Look for the lot number on the blister pack: N01530 or N01540 with expiration date January 2025.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0212-2025 (January 13, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0212-2025 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.